Unlocking the Future: Red Light Holland Collaborates with Arizona State University on Pioneering Psychedelic Genome Project Research

On June 19, 2025, Red Light Holland Corp., based in Ontario, announced an exciting partnership with Arizona State University. They are teaming up with Dr. Candace Lewis on a study called the “Psychedelic Genome Project.” This research seeks to explore how psilocybin, a compound found in some mushrooms, interacts with our genes and can impact our health in new ways.

This study comes at a time when the legalization of psychedelics is gaining momentum worldwide. The findings may help in creating tailored psychedelic treatments for individuals, revolutionizing the future of mental health care.

Red Light Holland is fully supporting this study in several ways:

• Recruitment: They’ll share study details through newsletters, social media, and their website, helping to recruit participants.
• Sample Kits: The company will manage the delivery and return of saliva collection kits for participants who agree to join the study.
• Collaboration: Staff training and regular check-ins will ensure everything runs smoothly throughout the research process.

Shashkes, Red Light Holland’s CTIO, expressed enthusiasm about the partnership. He noted that understanding how psilocybin influences genetic expression is crucial for future breakthroughs in psychedelic research.

Dr. Lewis also shared her excitement about the collaboration. She aims to identify biological markers that could lead to more effective psychedelic therapies. This focus on the epigenome could change how we perceive and use these substances for healing.

Statistics show that interest in psychedelic research has surged in recent years. According to a 2022 survey by the American Psychological Association, nearly 60% of therapists report wanting to incorporate psychedelic therapy into their practice. This growing demand highlights the importance of studies like the one being conducted with Red Light Holland.

Red Light Holland’s CEO, Todd Shapiro, emphasizes that their partnership represents a notable step forward for psychedelic research and personalized medicine. By leveraging their resources and customer relationships in the Netherlands, they are making substantial contributions to the study.

As this study progresses, it could pave the way for innovative treatments that combine genetics and psychedelics—offering hope for many seeking alternative therapies.

For more information on Arizona State University and Dr. Candace Lewis, visit www.asu.edu.

Source link

red,light,holland,partners,arizona,state,university,support,psychedelic,genome,project,pgp,research,study